ArticleClinical pharmacology and therapeutics2016

The value of routine pharmacogenomic screening-Are we there yet? A perspective on the costs and benefits of routine screening-shouldn't everyone have this done?

D L VeenstraPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.